Cargando…

Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial

INTRODUCTION: Catheter ablation is the preferred treatment for typical atrial flutter (AFl), but it can be challenging due to anatomical abnormalities. The use of 3D electroanatomical mapping systems (EAMS) has reduced fluoroscopy exposure during AFl ablation. Intracardiac echocardiography (ICE) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Debreceni, Dorottya, Janosi, Kristof-Ferenc, Turcsan, Marton, Toth, Daniel, Bocz, Botond, Simor, Tamas, Kupo, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601457/
https://www.ncbi.nlm.nih.gov/pubmed/37900565
http://dx.doi.org/10.3389/fcvm.2023.1244137
_version_ 1785126201051840512
author Debreceni, Dorottya
Janosi, Kristof-Ferenc
Turcsan, Marton
Toth, Daniel
Bocz, Botond
Simor, Tamas
Kupo, Peter
author_facet Debreceni, Dorottya
Janosi, Kristof-Ferenc
Turcsan, Marton
Toth, Daniel
Bocz, Botond
Simor, Tamas
Kupo, Peter
author_sort Debreceni, Dorottya
collection PubMed
description INTRODUCTION: Catheter ablation is the preferred treatment for typical atrial flutter (AFl), but it can be challenging due to anatomical abnormalities. The use of 3D electroanatomical mapping systems (EAMS) has reduced fluoroscopy exposure during AFl ablation. Intracardiac echocardiography (ICE) has also shown benefits in reducing radiation exposure during AFl ablation. However, there is a lack of evidence on the feasibility of ICE-guided, zero-fluoroscopy AFl ablation without the use of EAMS. METHODS: In this prospective study, we enrolled 80 patients with CTI-dependent AFl. The first 40 patients underwent standard fluoroscopy + ICE-guided ablation (Standard ICE group), while the other 40 patients underwent zero-fluoroscopy ablation using only ICE (Zero ICE group). Procedure outcomes, including acute success, procedure time, fluoroscopy time, radiation dose, and complications, were compared between the groups. RESULTS: The acute success rate was 100% in both groups. Out of the 40 cases, the zero-fluoroscopy strategy was successfully implemented in 39 cases (97.5%) in the Zero ICE group. There were no significant differences in procedure time [55.5 (46.5; 66.8) min vs. 51.5 (44.0; 65.5), p = 0.50] and puncture to first ablation time [18 (13.5; 23) min vs. 19 (15; 23.5) min, p = 0.50] between the groups. The Zero ICE group had significantly lower fluoroscopy time [57 (36.3; 90) sec vs. 0 (0; 0) sec, p < 0.001] and dose [3.17 (2.27; 5.63) mGy vs. 0 (0; 0) mGy, p < 0.001] compared to the Standard ICE group. Total ablation time was longer in the Standard ICE group [597 (447; 908) sec vs. 430 (260; 750), p = 0.02], but total ablation energy [22,458 (14,836; 31,116) Ws vs. 17,043 (10,533; 29,302) Ws, p = 0.10] did not differ significantly. First-pass bidirectional conduction block of the CTI and acute reconnection rates were similar between the groups. No complications or recurrences were observed during the follow-up period. CONCLUSION: Our study suggests that zero-fluoroscopy CTI ablation guided solely by ICE for AFl is feasible and safe. Further investigation is warranted for broader validation.
format Online
Article
Text
id pubmed-10601457
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106014572023-10-27 Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial Debreceni, Dorottya Janosi, Kristof-Ferenc Turcsan, Marton Toth, Daniel Bocz, Botond Simor, Tamas Kupo, Peter Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: Catheter ablation is the preferred treatment for typical atrial flutter (AFl), but it can be challenging due to anatomical abnormalities. The use of 3D electroanatomical mapping systems (EAMS) has reduced fluoroscopy exposure during AFl ablation. Intracardiac echocardiography (ICE) has also shown benefits in reducing radiation exposure during AFl ablation. However, there is a lack of evidence on the feasibility of ICE-guided, zero-fluoroscopy AFl ablation without the use of EAMS. METHODS: In this prospective study, we enrolled 80 patients with CTI-dependent AFl. The first 40 patients underwent standard fluoroscopy + ICE-guided ablation (Standard ICE group), while the other 40 patients underwent zero-fluoroscopy ablation using only ICE (Zero ICE group). Procedure outcomes, including acute success, procedure time, fluoroscopy time, radiation dose, and complications, were compared between the groups. RESULTS: The acute success rate was 100% in both groups. Out of the 40 cases, the zero-fluoroscopy strategy was successfully implemented in 39 cases (97.5%) in the Zero ICE group. There were no significant differences in procedure time [55.5 (46.5; 66.8) min vs. 51.5 (44.0; 65.5), p = 0.50] and puncture to first ablation time [18 (13.5; 23) min vs. 19 (15; 23.5) min, p = 0.50] between the groups. The Zero ICE group had significantly lower fluoroscopy time [57 (36.3; 90) sec vs. 0 (0; 0) sec, p < 0.001] and dose [3.17 (2.27; 5.63) mGy vs. 0 (0; 0) mGy, p < 0.001] compared to the Standard ICE group. Total ablation time was longer in the Standard ICE group [597 (447; 908) sec vs. 430 (260; 750), p = 0.02], but total ablation energy [22,458 (14,836; 31,116) Ws vs. 17,043 (10,533; 29,302) Ws, p = 0.10] did not differ significantly. First-pass bidirectional conduction block of the CTI and acute reconnection rates were similar between the groups. No complications or recurrences were observed during the follow-up period. CONCLUSION: Our study suggests that zero-fluoroscopy CTI ablation guided solely by ICE for AFl is feasible and safe. Further investigation is warranted for broader validation. Frontiers Media S.A. 2023-10-12 /pmc/articles/PMC10601457/ /pubmed/37900565 http://dx.doi.org/10.3389/fcvm.2023.1244137 Text en © 2023 Debreceni, Janosi, Turcsan, Toth, Bocz, Simor and Kupo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Debreceni, Dorottya
Janosi, Kristof-Ferenc
Turcsan, Marton
Toth, Daniel
Bocz, Botond
Simor, Tamas
Kupo, Peter
Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
title Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
title_full Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
title_fullStr Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
title_full_unstemmed Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
title_short Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
title_sort feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601457/
https://www.ncbi.nlm.nih.gov/pubmed/37900565
http://dx.doi.org/10.3389/fcvm.2023.1244137
work_keys_str_mv AT debrecenidorottya feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial
AT janosikristofferenc feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial
AT turcsanmarton feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial
AT tothdaniel feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial
AT boczbotond feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial
AT simortamas feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial
AT kupopeter feasibilityandsafetyofcavotricuspidisthmusablationusingexclusiveintracardiacechocardiographyguidanceaproofofconceptobservationaltrial